Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03749616 · ClinicalTrials.gov registry record · Phase 4

Effect of NSAID Use on Pain and Opioid Consumption Following Distal Radius Fracture

A Phase 4 study, sponsored by University of Missouri-Columbia.

Terminated
Registry status
Phase 4
Development phase
32
Enrollment target

NCT03749616: Clinical Trial Phase 4 study, sponsored by University of Missouri-Columbia.

NCT03749616 is a Phase 4 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 32 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03749616, a Phase 4 study, was terminated before completion, sponsored by University of Missouri-Columbia.

TERMINATED
Registry status
Phase 4
Development phase
32 participants
Enrollment target

Study Summary

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are excellent medications for providing pain control in certain patients. There is some data to suggest that NSAIDs can be used to reduce postoperative pain and narcotic use in patients who had undergone carpal tunnel release. There are mixed results about the effect of bone healing in adult patients with broken bones. The investigators hypothesize that NSAID administration in the acute phase of distal radius fracture healing will be non-inferior for pain control and decrease the use of opioid analgesics compared to patients who take acetaminophen for pain control during this same time period. Furthermore, the investigators hypothesize that patients will have similar or better patient reported outcomes, range of motion, and strength with the administration of NSAIDs.

Primary Outcome

The number and dosing of oxycodone tablets taken per participant for breakthrough pain will be recorded.

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2019-01-02
Est. Completion 2022-03-24
Phase Phase 4
University of Missouri-Columbia

291 total trials

Why NCT03749616 stopped before completion

NCT03749616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.

NCT03749616 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03749616 about?

NCT03749616 is a clinical study titled "Effect of NSAID Use on Pain and Opioid Consumption Following Distal Radius Fracture". Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are excellent medications for providing pain control in certain patients. There is some data to suggest that NSAIDs can be used to reduce postoperative pain and narcotic use in patients who had undergone carpal tunnel release. There ...

What is the current status of trial NCT03749616?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2019-01-02. Estimated completion is 2022-03-24.

What interventions are being tested in trial NCT03749616?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT03749616?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03749616's enrollment target sits among peer trials

32 1534th of 2000 higher than 457 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03749616, the US trial registry maintained by the National Library of Medicine. NCT03749616 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.